| News & Press Releases

AminoSib® trademark is registered in the USA


Aminosib continues to develop market significance, both conventionally and by country. The trademark is currently registered in countries such as Russia, Armenia, Kyrgyzstan, Kazakhstan, Turkey, Belarus, and the United States.

At the end of 2021, the AminoSib® trademark was officially registered by the U.S. Patent and Trademark Office (an agency of the U.S. Department of Commerce).

Патент на товарный знак AminoSib®